The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: Ghana remains an attractive investment prospect for foreign drugmakers operating in Sub-
Saharan Africa, and stabilising the national health insurance scheme provides an upside risk to our outlook
for the pharmaceutical sector. The Ghanaian government is actively making progress towards fulfilling its
ambition of being the Economic Communities of West African States (ECOWAS) hub for pharmaceutical
and healthcare investment.
Headline Expenditure Projections
Pharmaceuticals: GHS1.18bn (USD310mn) in 2015 to GHS1.30bn (USD320mn) in 2016; +10.9% in local
currency terms and +4.3% in US dollar terms. Forecast in line with Q316.
Healthcare: GHS4.39bn (USD1.16bn) in 2015 to GHS4.78bn (USD1.19bn) in 2016; +8.9% in local
currency terms and +2.4% in US dollar terms. Forecast in line with Q316.